<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05051176</url>
  </required_header>
  <id_info>
    <org_study_id>4168/2021/ODDZ-11065</org_study_id>
    <nct_id>NCT05051176</nct_id>
  </id_info>
  <brief_title>Prevalence of Diastasis m. Rectus Abdominis in Postpartum Women</brief_title>
  <official_title>Prevalence of Diastasis m. Rectus Abdominis and the Relationship Between Diastasis and Pelvic Floor Muscle Dysfunction in Postpartum Women</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Pavol Jozef Safarik University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Pavol Jozef Safarik University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will evaluate the prevalence of diastasis m. rectus abdominis after delivery.&#xD;
&#xD;
      And relations between diastasis of m. rectus abdominis and pelvic floor muscle dysfunction in&#xD;
      woman after delivery.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Evaluation of the width of the album lineage within the evaluation of diastasis of the rectus&#xD;
      abdominis by 2D and 3D USG with evaluation, relation to pelvic floor dysfunctions, such as&#xD;
      pain, urinary incontinence and prolapse, by evaluating pelvic floor muscle tone, pelvic floor&#xD;
      muscle strength and endurance, and urethral hypermobility.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 8, 2021</start_date>
  <completion_date type="Anticipated">April 29, 2022</completion_date>
  <primary_completion_date type="Anticipated">February 28, 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Detection of the prevalence of diastasis of the rectus abdominis in postpartum women.</measure>
    <time_frame>Six weeks to up to 6 months after birth</time_frame>
    <description>IRD distance measured by a linear probe 2D usg, 4.5 cm above the navel, 4.5 cm below the navel.&#xD;
At rest, with maximum inhaling and exhaling, when raising the torso and when raising the lower limbs.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Determination of the relationship between diastasis and multiple dysfunctions of the pelvic floor muscles in postpartum women .</measure>
    <time_frame>Six weeks to up to 6 months after birth.</time_frame>
    <description>Occurrence of stress urinary incontinence over one week. Occurrence of several urinary leakages during the day, measured using the International Consultation on Incontinence Questionnaire - Urinary Incontinence Short Form (ICIQ-UI Short Form).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Occurrence of an overactive bladder over one week.</measure>
    <time_frame>Six weeks to up to 6 months after birth.</time_frame>
    <description>Occurrence of several voidings and intensity of urgencies during 24 hours using the Overactive Bladder Questionnaire (OAB - q)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Occurrence of - cystocele, rectocele, and prolapse of the uterus.</measure>
    <time_frame>Six weeks to up to 6 months after birth.</time_frame>
    <description>Occurrence of - cystocele, rectocele, and prolapse of the uterus by ultrasound and standard gynaecological examination. A validated questionnaire to assess the symptoms and quality of life of women with urogenital prolapse (P-Qol) was used.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in incontinence quality of life using Urinary Incontinence Quality of Life Scale (I-QoL).</measure>
    <time_frame>Six weeks to up to 6 months after birth.</time_frame>
    <description>The I-QoL is composed of three subscales (avoidance and limiting behaviour; psychosocial impact; social embarrassment) and comprises 22 questions with a total score in the range from 0 (worst quality of life) to 100 (best quality of life).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Occurrence of low back pain.</measure>
    <time_frame>Six weeks to up to 6 months after birth.</time_frame>
    <description>Occurrence of low back pain using the Oswestry Disability Index (ODI).</description>
  </secondary_outcome>
  <enrollment type="Anticipated">150</enrollment>
  <condition>Diastasis of m. Rectus Abdominis</condition>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>2D usg and 3D usg</intervention_name>
    <description>IRD distance measured by a linear probe 2D usg. Occurrence of - cystocele, rectocele, and prolapse of the uterus by ultrasound and standard gynaecological examination.</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Women from six weeks to up to 6 months after birth, age over 18 years old.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Women from six weeks to up to 6 months after birth, age over 18 years old.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Psychiatric illness, postpartum depression, non-cooperation. Neurological diseases&#xD;
             conditions after a stroke, a history of brain injury, significant visual and hearing&#xD;
             damage, confirmed by neurological examination. Serious internal, orthopedic and&#xD;
             oncological diseases. Disagreement with inclusion in the study.&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Rastislav Dudič, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Gynecology and Obstetrics, Medical Faculty, PJ Safarik University, Kosice, Slovakia</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Magdalena Hagovska, Prof,PhD</last_name>
    <role>Study Director</role>
    <affiliation>KFBLR, Medical Faculty, PJ Safarik University, Kosice, Slovakia</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jan Svihra, Prof,MD,PhD.</last_name>
    <role>Study Director</role>
    <affiliation>Department of Urology, Institution, Comenius University Bratislava, Slovakia</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Rastisav Dudic, MD,PhD</last_name>
    <phone>+421918450477</phone>
    <email>rastislavdudic.rd@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Magdalena Hagovska, Prof,PhD</last_name>
    <phone>+421944400846</phone>
    <email>magdalena.hagovska@upjs.sk</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>PJ Safarik University</name>
      <address>
        <city>Košice</city>
        <zip>04011</zip>
        <country>Slovakia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rastislav Dudič, PhD</last_name>
      <phone>+421918450477</phone>
      <email>rastislavdudic.rd@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Magdalena Hagovska, PhD</last_name>
      <phone>+421944400846</phone>
      <email>magdalena.hagovska@upjs.sk</email>
    </contact_backup>
    <investigator>
      <last_name>Jan Svihra, Prof., PhD.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Magdalena Hagovska, Assoc.Prof., PhD.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Slovakia</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>September 10, 2021</study_first_submitted>
  <study_first_submitted_qc>September 10, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">September 21, 2021</study_first_posted>
  <last_update_submitted>September 10, 2021</last_update_submitted>
  <last_update_submitted_qc>September 10, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 21, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Pavol Jozef Safarik University</investigator_affiliation>
    <investigator_full_name>Rastislav Dudič, MD, PhD.</investigator_full_name>
    <investigator_title>Faculty of Medicine</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

